Michael W Flanagan

Title: Michael W. Flanagan: Innovator in RNA Interference Technology

Introduction

Michael W. Flanagan is a notable inventor based in Menlo Park, California. He has made significant contributions to the field of gene expression modulation through his innovative research and patents. His work primarily focuses on RNA interference, a crucial mechanism in gene regulation.

Latest Patents

Flanagan holds a patent for "RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)." This invention relates to compounds, compositions, and methods for studying, diagnosing, and treating various traits, diseases, and conditions that can be influenced by modulating gene expression. Specifically, it involves double-stranded nucleic acid molecules, including small nucleic acid molecules like siNA, which are capable of mediating RNA interference against target gene expression. He has 1 patent to his name.

Career Highlights

Flanagan is currently associated with Sirna Therapeutics, Inc., where he continues to advance his research in RNA technology. His work has the potential to impact various medical fields, particularly in the treatment of genetic disorders and diseases.

Collaborations

Throughout his career, Flanagan has collaborated with notable colleagues, including Mark Cancilla and James J. Cunningham. These partnerships have fostered innovation and contributed to the advancement of their shared research goals.

Conclusion

Michael W. Flanagan is a prominent figure in the field of RNA interference, with a focus on gene expression modulation. His contributions through patents and collaborations highlight his commitment to advancing medical science and technology.